NCT00038987View on ClinicalTrials.gov

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

August 31, 2002

Conditions
Smallpox
Interventions
BIOLOGICAL

Wetvax (APSV)

Trial Locations (4)

52242

University of Iowa - Iowa City IA, Iowa City

77030

Baylor College of Medicine, Houston

94611

Kaiser Permanente Vaccine Study Center, Oakland

37232-26

Vanderbilt University, Nashville

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00038987 - Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT | Biotech Hunter | Biotech Hunter